600276.SS
Latest Trade
100.50CNYChange
-0.85(-0.84%)Volume
25,083,124Today's Range
-
101.3552 Week Range
-
116.87As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 101.35 |
|---|---|
Open | 100.18 |
Volume | 25,083,124 |
3M AVG Volume | 649.18 |
Today's High | 101.35 |
Today's Low | 98.59 |
52 Week High | 116.87 |
52 Week Low | 64.32 |
Shares Out (MIL) | 5,331.72 |
Market Cap (MIL) | 540,369.50 |
Forward P/E | 83.09 |
Dividend (Yield %) | 0.19 |
Jiangsu Hengrui Medicine Agrees To Invest $20 Mln In Yingli Pharma For 6.67% Stake
Jiangsu Hengrui Medicine Says 9-Month Net Profit Up 14.0% Y/Y
Jiangsu Hengrui Medicine's H1 Net Profit Up 10.3% Y/Y
JIANSU HENGRUI MEDICINE CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.
Industry
Biotechnology & Drugs
Contact Info
No.7 Kunlunshan Road
Lianyungang Eco & Tech Development Zone
LIANYUNGANG, JNG
222000
China
+86.518.81220983
http://www.hrs.com.cnExecutive Leadership
Yunshu Zhou
Chairman of the Board, General Manager
Song Zhou
Chief Financial Officer
Hongbin Dai
Deputy General Manager, Director
Jieping Sun
Deputy General Manager, Director
Lianshan Zhang
Deputy General Manager, Director
Price To Earnings (TTM) | 80.31 |
|---|---|
Price To Sales (TTM) | 20.98 |
Price To Book (MRQ) | 15.87 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 0.00 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | 22.56 |
Return on Equity (TTM) | 19.96 |
China's blue-chip index ended higher for the fourth straight session on Thursday, powered by healthcare, consumer staples and financials sectors, on investor optimism over swift recovery in the world's second-largest economy. ** At the close, the Shanghai Composite index...
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.